Abstract
BackgroundThe role of thrombotic factors in the pathogenesis and progression of liver fibrosis remains obscure. We aimed to study the relationship between prothrombin G20210A (PT20210) and factor V Leiden (FVL) mutations and the progression of fibrosis and liver function in chronic HCV patients.MethodsThe study included 100 subjects, 88 patients with HCV-related cirrhosis (compensated: 38, decompensated: 50), and 12 controls. Patients with other viral hepatitis or coinfection, inherited metabolic disease, autoimmune hepatitis, hepatic or extrahepatic malignancy, in addition to patients with causes of hypoalbuminemia, elevated bilirubin or prolonged INR not related to cirrhosis were excluded from the study. Relevant clinical data were collected and basic laboratory tests were performed. Liver fibrosis was assessed using APRI and FIB-4 scores. FVL and PT20210 mutations were analyzed.ResultsFVL and PT20210 mutations were significantly higher in decompensated vs. compensated patients (32% vs. 5.3%, P = 0.001; 20% vs. 5.3%, 0.043, respectively) and absent in controls. Both mutations significantly correlated to the duration of infection, platelet count and fibrosis scores. PT20210 mutation significantly correlated to serum albumin and INR. Both mutations significantly predicted fibrosis scores, especially PT20210 (AUROC: 0.833 for APRI and 0.895 for FIB-4).ConclusionsBoth mutations are significantly correlated to fibrosis progression and liver profile and could be considered as markers predicting the need for early and different intervention.
Publisher
Public Library of Science (PLoS)
Reference39 articles.
1. Organization WH. Global hepatitis report 2017. World Health Organization, 2017.
2. Ministry of Health E, El-Zanaty, Associates E, and International I. Egypt Health Issues Survey. Ministry of Health and ICF International Cairo, Egypt and Rockville, MD, USA, 2015.
3. Screening and Treatment Program to Eliminate Hepatitis C in Egypt;I Waked;New England Journal of Medicine,2020
4. Impact of new direct-acting antiviral drugs on hepatitis C virus-related decompensated liver cirrhosis;M Essa;European Journal of Gastroenterology & Hepatology,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献